Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis

Author： Jagessar S.  

Publisher： Springer Publishing Company

ISSN： 1557-1890

Source： Journal of Neuroimmune Pharmacology, Vol.7, Iss.1, 2012-03, pp. : 253-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Immunomodulation of Human Lymphocyte Proliferation and Cytokine (Interferon-γ) Production of Four Novel Leflunomide Analogues

By  

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 799-804

Bentham Science Publishers

Access to resources Recommend Favorite

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A.   Rieckmann P.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite

Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis

By Verweij Cornelis L  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1883-1885

Future Medicine

Access to resources Recommend Favorite

Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis: Prevalence and Impact on Outcomes

By Deisenhammer Florian  

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite

Haematological Effects of Interferon-β-1a (Rebif ® ) Therapy in Multiple Sclerosis

By Rieckmann Peter  

Drug Safety, Vol. 27, Iss. 10, 2004-01 ,pp. : 745-756

Adis International

Access to resources Recommend Favorite